바이오의약품 포장 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global biopharmaceutical packaging market size is expected to reach USD 55.78 Billion in 2034 from USD 25.43 Billion in 2025, growing at a CAGR of 9.12 during 2026-2034.This market is experiencing significant growth as the production of biologics, vaccines, biosimilars, and advanced therapeutics continues expanding worldwide. Biopharmaceutical packaging plays a critical role in maintaining product stability, sterility, and safety throughout storage and transportation. Rising investments in biotechnology research, pharmaceutical manufacturing, and cold chain logistics are increasing demand for high-performance packaging solutions across the healthcare industry.

Growing regulatory requirements regarding product safety, traceability, and contamination prevention are encouraging manufacturers to adopt advanced packaging materials and technologies. Increasing use of prefilled syringes, vials, cartridges, ampoules, and specialized containers for temperature-sensitive products is supporting market expansion. Technological advancements in smart packaging, tamper-evident systems, and sustainable packaging materials are further improving product protection and operational efficiency.

The market is expected to maintain strong momentum as personalized medicine, cell therapies, and biologic drug development continue accelerating. Continuous innovation in barrier materials, recyclable packaging solutions, and intelligent tracking technologies will enhance packaging performance while supporting sustainability goals. Expanding pharmaceutical manufacturing capacities and increasing global demand for biologic therapies will create substantial long-term growth opportunities.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Pre-Filled Syringes
• Vials & Ampoules
• Cartridges
• Bottles
• IV Bags & Containers
• Blister Packs
• Others

By Material

• Plastic Polymers
• Glass
• Others

By Drug Type

• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Insulin
• Cell Therapies
• Gene Therapies
• Biosimilars
• Others

COMPANIES PROFILED

• Amcor plc, Becton, Dickinson and Company, Bormioli Pharma S.p.A., Chongqing Zhengchuan Pharmaceutical Packaging Co. Ltd., Gerresheimer AG, LOG Pharma Packaging, Merck KGaA, Multipharma, Pacific Vial Manufacturing Inc., Piramal Glass Private Limited, SCHOTT AG, Shandong Pharmaceutical Glass Co. Ltd., Stevanato Group S.p.A., W. L. Gore & Associates Inc., West Pharmaceutical Services Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOPHARMACEUTICAL PACKAGING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Pre-Filled Syringes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Vials & Ampoules Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cartridges Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Bottles Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. IV Bags & Containers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Blister Packs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOPHARMACEUTICAL PACKAGING MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Plastic Polymers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Glass Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOPHARMACEUTICAL PACKAGING MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Drug Type
• 6.2. Monoclonal Antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Recombinant Proteins Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Insulin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Cell Therapies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Gene Therapies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Biosimilars Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOPHARMACEUTICAL PACKAGING MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Material
  • 7.2.3 By Drug Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Material
  • 7.3.3 By Drug Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Material
  • 7.4.3 By Drug Type
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Material
  • 7.5.3 By Drug Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Material
  • 7.6.3 By Drug Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOPHARMACEUTICAL PACKAGING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Amcor Plc
  • 9.2.2 Becton
  • 9.2.3 Dickinson And Company
  • 9.2.4 Bormioli Pharma S.p.A
  • 9.2.5 Chongqing Zhengchuan Pharmaceutical Packaging Co. Ltd
  • 9.2.6 Gerresheimer AG
  • 9.2.7 LOG Pharma Packaging
  • 9.2.8 Merck KGaA
  • 9.2.9 Multipharma
  • 9.2.10 Pacific Vial Manufacturing Inc
  • 9.2.11 Piramal Glass Private Limited
  • 9.2.12 SCHOTT AG
  • 9.2.13 Shandong Pharmaceutical Glass Co. Ltd
  • 9.2.14 Stevanato Group S.p.A
  • 9.2.15 W. L. Gore & Associates Inc
  • 9.2.16 West Pharmaceutical Services Inc